Stay updated on Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe study record is unavailable: the page now shows a “Failed to fetch” error instead of a 403 Forbidden message, and the NIH transition notice is no longer displayed.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study record still displays a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer shows a newer site revision number, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied screen and a Home option. This indicates the record is currently inaccessible due to permissions.SummaryDifference19%

Stay in the know with updates to Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.